National STD Curriculum from the University of Washington STD Prevention Training Center. Provides information on different STDs and STIs, which are available for Quick Reference. There is also the option to Self-Study, allowing the user to track progress and receive Continuing Education credit.
From the CDC Morbidity and Mortality Weekly Report, Vol. 70, No. 4, published July 23, 2021.
Summary: "These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11–14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs."
- STI-Guidelines-2021.pdf (4.24 MB)
CDC framework for assisting clinicians in discussing the sexual health issues of a patient in order to obtain a more complete picture of the patient's overall health. The guide covers the clinical environment, the Five "P"s, and other dialogue with the patient that may arise by the end of the session.
CDC Guidelines, for clinicians, on the use of doxy PEP for the prevention of bacterial STIs. Provides education on prescribing doxy PEP (such as who benefits and for which STIs, potential side effects, etc.), what is still being researched, and a list of additional resources.
- La-gripe-aviar-y-tu-seguridad-Guia-para-trabajadores-de-lecherias_2024-5-14.pdf (1.11 MB)
- Avian-Flu-and-Your-Safety-Guidance-for-Dairy-Workers_2024-4-16.pdf (1.11 MB)
- La-gripe-aviar-y-tu-seguridad-Guia-para-trabajadores-de-lecherias_2024-5-14.png (456.92 KB)
- Avian-Flu-and-Your-Safety-Guidance-for-Dairy-Workers_2024-4-16.png (458.15 KB)
Covid-19 y nuestra comunidad ¡Más vale prevenir que lamentar! es un material educativo para apoyar la labor de los promotores de salud comunitaria sobre COVID-19 y su prevención. Se complementa con una guía con sugerencias concretas de como usar el rotafolio y enlaces a recursos para quienes quieren profundizar en el tema e investigar si hay algún cambio en la información.
El rotafolio incluye conceptos básicos de COVID-19, la prevención y la vacunación en forma de mensajes claros y sencillos que se apoyan en ilustraciones culturalmente apropiadas para facilitar el proceso de comunicación y transmisión de información a los miembros de la comunidad. Usted puede descargar gratuitamente estos recursos tanto en inglés como en español.
"Coccidioidomycosis or Valley Fever is an infectious disease in parts of the U.S.A. It is caused by inhaling microscopic arthroconidia (also known as arthrospores or spores) of the closely related fungal species Coccidioides immitis and C. posadasii. Areas where Coccidioides is endemic (native and common) include states in the southwestern U.S.A. such as Arizona, California, New Mexico, Nevada, Texas, and Utah and parts of Mexico, Central America and South America."
"Emerging Infectious Diseases is an open access journal published monthly by the Centers for Disease Control and Prevention (CDC)." ... "Emerging Infectious Diseases follows the International Committee of Medical Journal Editors recommendations for the conduct, reporting, editing, and publishing of scholarly work in medical journals. The journal’s peer review process allows for critical assessment of submitted manuscripts by experts who are usually not part of its editorial staff. As an independent publication, the journal’s peer-review process operates independently from CDC’s clearance processes."
This resource helps you address stigmatization by providing best practices for inhibiting and the actions to take when you encounter stigmatization when new infectious diseases and illness emerge.
Early in an outbreak, such as the 2009 H1N1 outbreak, groups of people, places, and animals can be singled out and will be at risk of being stigmatized by association with the threat this virus poses. Groups are stigmatized by an infectious disease when the risk of infection to others is not present or remote but the association of the risk is magnified by others for that population group, or place or animal.
- CERC Stigmatization fact sheet.doc (89.5 KB)